Ribavirin and Colecalciferol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ribavirin (ribavirin) and Colecalciferol (cholecalciferol). Common drug interactions include abdominal pain among females and jaundice among males.

The phase IV clinical study analyzes what interactions people have when they take Ribavirin and Colecalciferol. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Ribavirin?

Ribavirin has active ingredients of ribavirin. It is often used in hepatitis c. eHealthMe is studying from 78,532 Ribavirin users. Check the latest studies of Ribavirin.

What is Colecalciferol?

Colecalciferol has active ingredients of cholecalciferol. eHealthMe is studying from 21,262 Colecalciferol users. Check the latest studies of Colecalciferol.



On Jul, 11, 2026

19 people who take Ribavirin and Colecalciferol together, and have interactions are studied.

Ribavirin and Colecalciferol drug interactions.

What are the common drug interactions of Ribavirin and Colecalciferol, by gender? *:

female:

  1. Abdominal pain
  2. Constipation
  3. Pyrexia (fever)
  4. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  5. Anaemia (lack of blood)
  6. Blood pressure increased
  7. Deafness
  8. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  9. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  10. Tremor (trembling or shaking movements in one or more parts of your body)

male:

  1. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  2. Acute hepatic failure
  3. Hepatocellular carcinoma (liver cancer)
  4. Acute psychosis (period of mentally unstable behaviour)
  5. Alanine aminotransferase increased
  6. Anaemia (lack of blood)
  7. Ascites (accumulation of fluid in the abdominal cavity)
  8. Aspartate aminotransferase increased
  9. Base excess decreased
  10. Blood bicarbonate decreased

What are the common drug interactions of Ribavirin and Colecalciferol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Leukopenia (less number of white blood cells in blood)
  2. Neutropenia (an abnormally low number of neutrophils)
  3. Platelet count decreased
  4. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  5. White blood cell count decreased

40-49:

  1. Acute hepatic failure
  2. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  3. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  4. Portal vein thrombosis (venous thrombosis affecting the hepatic portal vein)
  5. Acute psychosis (period of mentally unstable behaviour)
  6. Complex partial seizures (epileptic seizure)
  7. Reactive psychosis (extreme stress)

50-59:

  1. Renal failure acute (rapid kidney dysfunction)
  2. Alanine aminotransferase increased
  3. Ascites (accumulation of fluid in the abdominal cavity)
  4. Aspartate aminotransferase increased
  5. Base excess decreased
  6. Blood bicarbonate decreased
  7. Blood bilirubin increased
  8. Blood calcium decreased
  9. Blood glucose increased
  10. Blood sodium decreased

60+:

  1. Anaemia (lack of blood)
  2. Hepatocellular carcinoma (liver cancer)
  3. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  4. Blood pressure increased
  5. Deafness
  6. Drug ineffective
  7. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  8. Photosensitivity reaction
  9. Tremor (trembling or shaking movements in one or more parts of your body)

What are the existing conditions these people have? *

  1. High Blood Pressure: 3 people, 15.79%
  2. Rickets (softening of bones): 3 people, 15.79%
  3. Erection Problems: 3 people, 15.79%
  4. Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 2 people, 10.53%
  5. Diabetes: 2 people, 10.53%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.53%
  7. Schizoaffective Disorder (a mental disorder characterized by disordered thought): 2 people, 10.53%
  8. Hepatic Steatosis (fatty liver disease): 2 people, 10.53%
  9. Anal Pruritus (anal itching): 2 people, 10.53%
  10. Pain: 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Ribavirin and Colecalciferol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ribavirin and Colecalciferol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ribavirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Colecalciferol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ribavirin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Colecalciferol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ribavirin and cholecalciferol (the active ingredients of Ribavirin and Colecalciferol, respectively), and Ribavirin and Colecalciferol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: